Position Paper - Europabio

About us
- What we do
- Who we are
Members
- EuropaBio Members
- About Membership
How we work
Activities
News & Events
- News
- Events
Library

Become a member

21/02/2024

EC Initiative on Biotechnology and Biomanufacturing: Principles for an impactful Europe
08/02/2024

EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology
27/10/2023

EFIB Rotterdam Statement 2023
24/10/2023

Innovative biotech industry can support Europe’s health resilience and autonomy
09/10/2023

The Future of Health is Biotech: EuropaBio’s Position on the Revision of the EU Pharmaceutical Legislation
14/09/2023

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products
14/09/2023

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework
28/07/2023

EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management
17/07/2023

EuropaBio position paper for the proposal on establishing a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem (Net-Zero Industry Act)
13/07/2023

Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs
05/07/2023

The NGT proposal is an important step towards Europe’s bioeconomy-driven strategic autonomy, competitiveness and sustainability ambitions
23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation
10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski
04/05/2023

EuropaBio response to the public consultation on EU Taxonomy Environmental Delegated Act
23/02/2023

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation
17/02/2023

Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics
01/02/2023

Joint Statement: The Data Act is a leap into the unknown
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework
16/11/2022

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides
09/09/2022

The Essential Role of Enzymes | The unintended impact of the REACH revision on Enzymes – and consequences for EU Green Deal Objectives

1 2 3 4 5

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Extra links

Newsroom

Become a member

Media pack

Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation